We evaluated cell surface expression of GRP78 in different peripheral blood mononuclear cell (PBMC) subpopulations of patients with breast cancer before, halfway, and at the end of the neoadjuvant treatment. This evidence concerns the gene HSPA5 and breast carcinoma.